+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East & Africa Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Age Group, and End User- Product Image
Middle East & Africa Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Age Group, and End User- Product Image
Sale

Middle East & Africa Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Age Group, and End User

  • PDF Icon

    Report

  • 100 Pages
  • November 2023
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5923301
UP TO OFF until Jun 30th 2024
Description Jump to:
The Middle East & Africa lung cancer screening market is expected to grow from US$ 17.52 million in 2022 to US$ 30.11 million by 2030. It is estimated to grow at a CAGR of 7.0% from 2022 to 2030.

Collaboration With Regional Hospitals and Clinics Fuel Middle East & Africa Lung Cancer Screening Market

Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region’s healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

Middle East & Africa Lung Cancer Screening Market Overview

The Middle East & Africa lung cancer screening market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. Factors that are driving the Middle East & Africa lung cancer screening market growth are increasing awareness of screening & diagnosis and growing initiatives by government and clinical & research institute. Iran, Iraq, Turkey, Kuwait, Qatar, Kenya, and Israel are among the major contributors to the lung cancer screening market in the Rest of Middle East & Africa. According to a report published in NCBI, in Qatar, lung cancer is a prevalent health condition, which can be attributed to the rising use of tobacco. The survival rate among lung cancer patients in Qatar is lower than the global average. Further, various factors such as distant metastasis, smoking status, and treatment history are associated with lung cancer survival in Qatar. Due to low survival rates, the Qatari government highly recommends screening for lung cancer. The Turkish Society of Lung Cancer had established a “Tobacco Control Committee” to promote tobacco control throughout Turkey and make the public aware of lung cancer as well as the need for screening. These factors propel the demand for lung cancer screening procedures in the Rest of the Middle East & Africa

Middle East & Africa Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Lung Cancer Screening Market Segmentation

The Middle East & Africa lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the Middle East & Africa lung cancer screening market is segmented into non-small cell lung cancer (NSCLC), and small cell lung cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the Middle East & Africa lung cancer screening market in 2022.

Based on technology, the Middle East & Africa lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the Middle East & Africa lung cancer screening market in 2022.

Based on age group, the Middle East & Africa lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Middle East & Africa lung cancer screening market in 2022.

Based on end user, the Middle East & Africa lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Middle East & Africa lung cancer screening market in 2022.

Based on country, the Middle East & Africa lung cancer screening market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa lung cancer screening market in 2022.

Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, GE HealthCare, and Nuance Communications Inc are some of the leading companies operating in the Middle East & Africa lung cancer screening market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Lung Cancer Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Lung Cancer Screening Market - by Technology
1.3.2 Middle East & Africa Lung Cancer Screening Market - by Cancer Type
1.3.3 Middle East & Africa Lung Cancer Screening Market - by Age Group
1.3.4 Middle East & Africa Lung Cancer Screening Market - by End User
1.3.5 Middle East & Africa Lung Cancer Screening Market - by Country
2. Middle East & Africa Lung Cancer Screening Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Lung Cancer Screening Market - Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Lung Cancer Screening Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.2 Market Restraints
5.2.1 Lack of Awareness regarding the Lung Cancer Screening:
5.3 Market Opportunities
5.3.1 Collaboration with Regional Hospitals and Clinics
5.4 Future Trends
5.4.1 Use of Cutting-Edge Technologies
5.5 Impact Analysis
6. Lung Cancer Screening Market - Middle East & Africa Market Analysis
6.1 Middle East & Africa Lung Cancer Screening Market Revenue Forecast and Analysis
7. Middle East & Africa Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type
7.1 Overview
7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Lung Cancer Screening Market Analysis - by Technology
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Lung Cancer Screening Market Analysis - by Age Group
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Lung Cancer Screening Market Analysis - by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis
11.1 Overview
11.1.1 Middle East & Africa: Lung Cancer Screening Market, by Key Country, 2020-2030 (%)
11.1.1.1 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.1.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.1.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.2.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.2.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.3.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.3.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.4.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.4.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.4.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12. Lung Cancer Screening Market-Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview
13. Company Profiles
13.1 Nuance Communications Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GE HealthCare
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Canon Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. South Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 2. South Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Growth Strategies in the Lung Cancer Screening Market
Table 18. Glossary of Terms
List of Figures
Figure 1. Middle East & Africa Lung Cancer Screening Market Segmentation
Figure 2. Middle East & Africa Lung Cancer Screening Market, by Country
Figure 3. Middle East & Africa Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Middle East & Africa Lung Cancer Screening Market
Figure 5. Middle East & Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9. Middle East & Africa Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
Figure 10. Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11. Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 15. Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 16. Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 18. Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 26. Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 27. South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Nuance Communications Inc
  • GE HealthCare Technologies Inc
  • Medtronic Plc
  • Canon Medical Systems Corp
  • Koninklijke Philips NV
  • Siemens AG

Table Information

Report AttributeDetails
No. of Pages100
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value in 2022 17.52 Million
Forecasted Market Value by 2030 30.11 Million
Compound Annual Growth Rate7.0%
Regions CoveredAfrica, Middle East

Related Topics

Related Reports

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography, Chest X-Ray, Liquid Biopsy, and Others], Age Group, and End User - Product Image

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography, Chest X-Ray, Liquid Biopsy, and Others], Age Group, and End User

  • Report
  • 188 Pages
  • Global
From
Lung Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis - Product Image

Lung Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • Report
  • 390 Pages
  • Global
From
Lung Cancer Diagnostic and Screening Global Market Report 2024 - Product Image

Lung Cancer Diagnostic and Screening Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Lung Cancer Screening Market Report and Forecast 2024-2032 - Product Image

Global Lung Cancer Screening Market Report and Forecast 2024-2032

  • Report
  • 180 Pages
  • Global
From
Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis - Product Image

Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis

  • Report
  • 200 Pages
  • Global
From

About the Lung Cancer Diagnostics Market

The Lung Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of tests and technologies that can detect and diagnose lung cancer. These tests can range from imaging techniques such as X-ray, CT scan, and MRI, to molecular tests such as gene sequencing and biomarker analysis. The goal of these tests is to detect lung cancer at an early stage, when it is most treatable. The Lung Cancer Diagnostics market is highly competitive, with many companies offering a variety of tests and technologies. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Hologic, and Becton Dickinson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.